Viridian Therapeutics, Inc.\DE VRDN Ratios (2013-2026)

NASDAQ VRDN
$22.92 -0.04 (-0.17%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Viridian Therapeutics, Inc.\DE Quarterly Ratios

Periods 53 quarters
Latest Jun 2026

Viridian Therapeutics, Inc.\DE reported a net margin of -44,396.13% for the quarter ended Jun 2026. These financial ratios cover 53 quarters of results from Jun 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
EBT Margin
-6,751.44%-13,526.17%-11,894.91%-11,519.92%-2,418.83%-43,604.76%-69,541.84%-76,476.39%-66,194.44%-92,593.06%-79,429.17%-101,333.33%-88,946.51%-110,373.61%-130,779.17%-134,313.33%-49.67%-89,575.00%-85,559.57%-44,396.13%
EBIT Margin
-6,795.19%-13,589.25%-11,985.65%-11,548.44%-2,492.47%-46,729.52%-73,952.04%-82,326.39%-71,144.44%-99,275.00%-77,634.72%-100,259.72%-97,069.77%-121,488.89%-130,369.44%-142,356.00%-56.70%-92,991.67%-82,389.36%-44,460.56%
EBITDA Margin
-6,795.19%-13,589.25%-11,985.65%-11,548.44%-2,492.47%-46,729.52%-73,952.04%-82,326.39%-71,144.44%-99,275.00%-77,634.72%-100,259.72%-97,069.77%-121,488.89%-130,369.44%-142,356.00%-56.70%-92,991.67%-82,389.36%-44,460.56%
Operating Margin
-6,795.19%-13,589.25%-11,985.65%-11,548.44%-2,492.47%-46,729.52%-73,952.04%-82,326.39%-71,144.44%-99,275.00%-77,634.72%-100,259.72%-97,069.77%-121,488.89%-130,369.44%-142,356.00%-56.70%-92,991.67%-82,389.36%-44,460.56%
Net Margin
-6,751.44%-13,526.17%-11,894.91%-11,519.92%-2,418.83%-43,604.76%-69,541.84%-76,476.39%-66,194.44%-92,593.06%-79,429.17%-101,333.33%-88,946.51%-110,373.61%-130,779.17%-134,313.33%-49.67%-89,575.00%-85,559.57%-44,396.13%
FCF Margin
-5,774.04%-7,765.89%-9,824.54%-7,178.91%-1,737.49%-32,640.95%-63,528.57%-63,020.83%-54,704.17%-52,844.44%-62,809.72%-64,113.89%-79,068.60%-102,008.33%-128,804.17%-100,553.33%-120.08%-18,177.27%-84,877.30%-37,545.77%
Efficiency
Inventory AverageInventory Avg.
Assets AverageAssets Avg.
169.70M212.46M193.44M176.49M305.20M437.84M410.87M369.05M340.11M409.59M560.40M608.02M678.78M757.15M701.69M621.65M579.73M738.28M844.22M943.12M
Invested CapitalInvested Cap.
187.72M146.48M413.62M399.71M355.23M320.57M303.58M462.23M602.86M549.79M728.02M692.22M625.16M535.96M523.86M772.11M686.44M775.74M
Asset Utilization RatioAsset Util.
0.020.010.010.010.010.000.000.000.000.000.000.000.000.000.000.000.120.100.080.08
Leverage & Solvency
Interest Coverage RatioInterest Cover
-0.01M-191.97-181.62-292.06-439.23-357.08-85.37-178.70-95.22-120.92-157.81-169.19-170.67-207.72-71.45-37.40-33.56-15.20
Debt Ratio
0.030.010.010.010.010.060.040.030.030.030.030.030.040.040.060.060.10
Times Interest Earned
-0.01M-191.97-181.62-292.06-439.23-357.08-85.37-178.70-95.22-120.92-157.81-169.19-170.67-207.72-71.45-37.40-33.56-15.20
Dividends & Payouts
Dividend Coverage RatioDiv. Cover
FCF Payout RatioFCF Cover
Payout Ratio
Valuation
Price to EarningsP/E
-13.10-8.14-17.22-11.17-28.56-20.47-16.07-18.82-14.07-14.62-19.53-11.39-23.55-19.54-11.68-11.33-50.62-22.32-16.61-16.50
Price to SalesP/S
884.470.00M0.00M0.00M690.720.01M0.01M0.01M0.01M0.01M0.02M0.01M0.02M0.02M0.02M0.02M25.150.02M0.01M0.01M
Price to BookP/B
0.901.262.652.322.022.373.123.282.362.211.921.572.552.311.822.223.533.653.153.14
Enterprise Value
-29.84M38.67M266.93M168.12M394.09M512.72M721.47M702.05M357.37M497.40M503.93M259.71M1,048.14M835.07M463.19M578.13M1,283.60M1,764.43M1,241.90M1,098.66M
EV to EBIT
2.11-1.33-10.31-5.69-13.23-10.45-9.96-11.84-6.98-6.96-9.02-3.60-12.56-9.55-4.93-5.41-32.08-14.37-10.69-8.70
EV to EBITDA
2.11-1.33-10.31-5.69-13.23-10.45-9.96-11.84-6.98-6.96-9.02-3.60-12.56-9.55-4.93-5.41-32.08-14.37-10.69-8.70
Market Capitalization
183.97M235.63M442.35M329.33M825.41M937.27M1,095.33M1,036.34M670.37M974.77M1,117.11M831.07M1,801.38M1,552.66M1,099.83M1,141.48M1,774.51M2,639.08M2,004.08M2,080.19M
Price to FCFP/FCF
-15.32-14.18-20.85-17.92-39.75-27.35-17.59-22.84-17.02-25.62-24.70-18.00-26.49-21.14-11.86-15.14-20.94-109.99-16.75-19.51
EV to FCF
2.48-2.33-12.58-9.15-18.98-14.96-11.59-15.47-9.07-13.07-11.14-5.63-15.41-11.37-4.99-7.67-15.15-73.54-10.38-10.30
EV to CFO
2.51-2.34-12.69-9.30-19.07-15.06-11.64-15.53-9.17-13.09-11.14-5.64-15.48-11.39-5.00-7.67-15.17-74.28-10.38-10.43
Return Ratios
Return on Sales [ROS]ROS
-6,795.19%-13,589.25%-11,985.65%-11,548.44%-2,492.47%-46,729.52%-73,952.04%-82,326.39%-71,144.44%-99,275.00%-77,634.72%-100,259.72%-97,069.77%-121,488.89%-130,369.44%-142,356.00%-56.70%-92,991.67%-82,389.36%-44,460.56%
Return on Capital Employed [ROCE]ROCE
-90.91%-40.10%-48.65%-63.62%-40.83%-33.20%-47.44%-61.87%-73.23%-66.44%-44.52%-43.90%-44.40%-42.16%-50.45%-65.30%-62.02%-54.43%-48.67%-46.08%
Return on Assets [ROA]ROA
-83.28%-37.41%-44.79%-55.63%-37.04%-29.66%-41.94%-53.62%-63.70%-57.99%-40.43%-40.21%-40.26%-37.79%-46.04%-56.44%-53.37%-47.16%-44.38%-42.41%